Table 2.
Characteristics of All Patients Eligible for Postdischarge Serology
| Characteristic | Completed Postdischarge Serology (n=445; 34.0%), No. (%) | Did Not Receive postdischarge Serology (n=865; 66.0%), No. (%) | P Valuea |
|---|---|---|---|
| Age, y | .02 | ||
| 18–49 | 107 (24.0) | 269 (31.1) | |
| 50–64 | 144 (32.4) | 232 (26.8) | |
| 65–74 | 131 (29.4) | 216 (25.0) | |
| 75–84 | 52 (11.7) | 121 (14.0) | |
| 85+ | 11 (2.5) | 27 (3.1) | |
| Median (IQR) | 63 (50–70) | 62 (43–71) | .24 |
| Race/Ethnicity | .16 | ||
| White, non-Hispanic | 417 (93.7) | 776 (89.7) | |
| Black | 8 (1.8) | 27 (3.1) | |
| Asian | 8 (1.8) | 19 (2.2) | |
| Hispanic of any race | 2 (0.5) | 11 (1.3) | |
| Other/Unknown | 10 (2.3) | 32 (3.7) | |
| Sex | .43 | ||
| Male | 235 (52.8) | 437 (50.5) | |
| Female | 210 (47.2) | 428 (49.5) | |
| Length of stay, median d (IQR) | 3 (2–5) | 3 (2–5) | .63 |
| ICU utilization, yes or no | 92 (20.7) | 218 (25.2) | .07 |
| Final postdischarge serology | |||
| Positive | 0 (0.0) | N/A | |
| Negative | 442 (99.3) | ||
| Indeterminateb | 3 (0.7) | ||
| Days from discharge to follow-up serology, median (IQR) | 15 (14–17) | N/A | |
| Postdischarge survey | .38 | ||
| 2+ symptoms | 7 (1.6) | 7 (0.8) | |
| 1 symptom only | 13 (2.9) | 10 (1.2) | |
| 0 symptoms | 146 (32.8) | 208 (24.0) | |
| Missing | 279 (62.7) | 640 (74.0) |
a
χ2 test for categorical variables, Wilcoxon rank-sum test for continuous variables.
b
No subsequent tests available.